BSE Live
Dec 10, 16:01Prev. Close
168.90
Open Price
164.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 10, 15:59Prev. Close
168.29
Open Price
165.00
Bid Price (Qty.)
169.55 (200)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Suven Life Sciences (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -106.40 | 0.16 | 195.53 | 27.65 | 23.95 | |
| Net CashFlow From Operating Activities | -193.85 | -52.61 | 69.94 | 109.17 | 67.50 | |
| Net Cash Used In Investing Activities | 205.55 | 37.13 | -0.61 | -310.64 | -38.63 | |
| Net Cash Used From Financing Activities | 2.74 | 4.53 | -52.07 | -30.39 | -68.07 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | -6.72 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 14.45 | -17.66 | 17.26 | -231.86 | -39.20 | |
| Cash And Cash Equivalents Begin of Year | 0.23 | 17.89 | 8.69 | 240.55 | 279.75 | |
| Cash And Cash Equivalents End Of Year | 14.68 | 0.23 | 25.95 | 8.69 | 240.55 |
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
13.05.2025
Suven Life Sci Standalone March 2025 Net Sales at Rs 1.47 crore, down 38.5% Y-o-Y
28.01.2025
Suven Life Sci Consolidated December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
13.05.2025
Suven Life Sci Standalone March 2025 Net Sales at Rs 1.47 crore, down 38.5% Y-o-Y
28.01.2025
Suven Life Sci Consolidated December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y